8-KOther EventsExhibits & Filings

WELLTOWER INC. 8-K Report, Corporate Update (Nov 19, 2014)

Filed November 19, 2014For Securities:WELL

Summary

Health Care REIT, Inc. (now Welltower Inc.) filed this Form 8-K on November 19, 2014, to report on two key events. Firstly, the company entered into an underwriting agreement on November 14, 2014, for the issuance of £500,000,000 in aggregate principal amount of 4.500% senior notes due 2034. This offering is expected to close on November 25, 2014, subject to customary conditions, indicating a move to raise significant capital through debt financing. Secondly, the report details the adoption of Rule 10b5-1 trading plans by two key executives, Jeffrey H. Miller and Erin C. Ibele. These plans allow for the structured sale of company stock and the exercise of stock options during specific future periods (December 2014 through July 2015). This action is taken to comply with regulations surrounding insider trading and to provide a clear framework for the executives' stock transactions, which will be reported on Form 4 filings.

Key Highlights

  • 1Health Care REIT, Inc. entered into an underwriting agreement to issue £500,000,000 in 4.500% senior notes due 2034.
  • 2The senior notes offering is expected to close on November 25, 2014.
  • 3The underwriting agreement was with a syndicate of prominent financial institutions including Deutsche Bank AG, Barclays Bank PLC, The Royal Bank of Scotland plc, UBS Limited, and Wells Fargo Securities, LLC.
  • 4Two key executives, Jeffrey H. Miller (COO) and Erin C. Ibele (EVP, Head of Human Capital), have adopted Rule 10b5-1 trading plans.
  • 5These plans enable the executives to sell company stock and exercise stock options within pre-defined periods, ensuring compliance with insider trading regulations.
  • 6Mr. Miller's plan allows for the sale of up to 4,259 shares and exercise/sale of up to 33,006 options between December 15, 2014, and July 31, 2015.
  • 7Ms. Ibele's plan allows for the sale of up to 4,400 shares and exercise/sale of up to 8,394 options between December 20, 2014, and July 31, 2015.

Frequently Asked Questions

This Form 8-K reports on two primary events: the execution of an underwriting agreement for a significant senior notes issuance and the establishment of Rule 10b5-1 trading plans by two key executives. These are important disclosures regarding the company's financing activities and executive stock transactions.

The company is issuing £500,000,000 aggregate principal amount of 4.500% senior notes due 2034. This indicates a significant debt financing strategy to raise capital.

The executives are entering into Rule 10b5-1 trading plans to comply with SEC regulations regarding insider trading. These plans allow them to sell company stock and exercise options in a structured manner at a time when they are not in possession of material non-public information, providing an affirmative defense against insider trading allegations.

The issuance of £500,000,000 in senior notes suggests the company is raising capital, likely for strategic initiatives such as acquisitions, development projects, or to refinance existing debt. Investors should look for further details in subsequent filings regarding the use of these proceeds and their impact on the company's financial leverage and interest expenses.